| Literature DB >> 6430624 |
Abstract
While antepartum prophylaxis of Rh immunization is much more costly and the postpartum program is much more cost-effective, the question is whether the antepartum program is sufficiently cost-effective to warrant its use. How, in any given region, should the issue be tackled? This article addresses that question.Mesh：
Substances：
Year: 1984 PMID： 6430624
Source DB: PubMed Journal: Clin Perinatol ISSN： 0095-5108 Impact factor: 3.430